PharmaShots Weekly Snapshots (September 20 - 24, 2021)
Published: Sept 24, 2021 | Tags: Everest, SPR206, NMPA, IND, Approval, MDR Gram-Negative Bacterial Infections
GE Healthcare to Acquire BK Medical for ~ $1.45B
Published: Sept 24, 2021 | Tags: GE Healthcare, Acquire, BK Medical, ~ $1.45B
Published: Sept 24, 2021 | Tags: Roche, Evrysdi, risdiplam, RAINBOWFISH, Study, Neuromuscular Disorder, WMS 2021
Published: Sept 24, 2021 | Tags: Pfizer, BioNTech, COVID-19 Vaccine Booster, US, FDA, EUA, COVID-19
Published: Sept 24, 2021 | Tags: Innovent, P-II, CIBI112A201 Trial, IBI112 Plaque Psoriasis
Published: Sept 24, 2021 | Tags: AstraZeneca, VaxEquity, Self-Amplifying RNA Therapeutics
Published: Sept 23, 2021 | Tags: Immunic, University Medical Center Goettingen, IMU-838, N4-Hydroxycytidine, Viral Infections
Gilead Reports Results of Veklury (remdesivir) in P-III Trial for the Treatment of COVID-19
Published: Sept 23, 2021 | Tags: Gilead, Veklury, remdesivir, P-III, Trial, COVID-19
Published: Sept 23, 2021 | Tags: Incyte, Jakafi, ruxolitinib, US, FDA, Approval, Chronic Graft-Versus-Host Disease
Published: Sept 23, 2021 | Tags: Abbott, Epic Plus Tissue Valves, US, FDA, Approval, Mitral, Aortic Valve Replacement
Published: Sept 23, 2021 | Tags: Innovent, NMPA, sNDA, Sintilimab, Esophageal Squamous Cell Carcinoma
AbCellera Enters into a License Agreement with Everest to Discover Antibody Therapies
Published: Sept 23, 2021 | Tags: AbCellera, Everest, Antibody Therapies
Published: Sept 22, 2021 | Tags: Vigeo, VT1021, P-I/II, Study, Recurrent Glioblastoma, Pancreatic Cancer
Published: Sept 22, 2021 | Tags: Takeda, Mirum, Maralixibat, Rare Pediatric Liver Diseases, Japan
Published: Sept 22, 2021 | Tags: Exelixis, Cabometyx, cabozantinib, P-III, COSMIC-311 Trial, Radioactive Iodine-Refractory DTC, ESMO 2021
Published: Sept 22, 2021 | Tags: Seagen, Genmab, Tivdak, tisotumab vedotin-tftv, US, FDA, Accelerated Approval, Cervical Cancer
Boehringer Ingelheim Acquires Abexxa to Expands its Immuno-oncology Research
Published: Sept 22, 2021 | Tags: Boehringer Ingelheim, Acquire, Abexxa, Cancer Immunocology Therapies
Published: Sept 22, 2021 | Tags: Incyte, Opzelura, ruxolitinib, US, FDA, Approval, Atopic Dermatitis
Boston Scientific to Acquire Devoro for ~$336M
Published: Sept 21, 2021 | Tags: Boston, Acquire, Devoro, ~$336M
Published: Sept 21, 2021 | Tags: Amgen, Verastem, VS-6766, Lumakras, Sotorasib, KRAS G12C-Mutant, Non-Small Cell Lung Cancer
Novartis to Acquire Arctos to Boost its Optogenetics Portfolio to Treat Eye Diseases
Published: Sept 21, 2021 | Tags: Novartis, Acquire, Arctos, Optogenetics Portfolio, Gene Therapies, Eye Diseases
Published: Sept 21, 2021 | Tags: Bayer, Gubra, Novel Peptide Therapeutics, Cardiorenal Diseases
Published: Sept 21, 2021 | Tags: Abbott, Portico, Flexnav Tavr System, US, FDA, Approval, Aortic Valve Disease
Published: Sept 21, 2021 | Tags: Samsung Bioepis, Biogen, Byooviz, biosimilar, ranibizumab, US, FDA, Approval, Retinal Vascular Disorders
Published: Sept 20, 2021 | Tags: AstraZeneca, Imfinzi, durvalumab. P-III, CASPIAN Trial, Extensive-Stage Small Cell Lung Cancer, ESMO 2021
Published: Sept 20, 2021 | Tags: Exelixis, Cabometyx, cabozantinib, US, FDA, Approval, Differentiated Thyroid Cancer
Published: Sept 20, 2021 | Tags: Merck, Keytruda, pembrolizumab, P-III, KEYNOTE-826 Trial, Cervical Cancer
Published: Sept 20, 2021 | Tags: Regeneron, Sanofi, Libtayo, cemiplimab, P-III, EMPOWER-Lung 3 Study, Advanced NSCLC, ESMO 2021
Published: Sept 20, 2021 | Tags: Mirati, Adagrasib, MRTX849, P-I/II, KRYSTAL1 Study, KRAS G12C-Mutated Colorectal Cancer, ESMO 2021
Published: Sept 20, 2021 | Tags: Everest, Sinovent, SinoMab, XNW1011, SN1011, Renal Diseases
Related Post: PharmaShots Weekly Snapshots (September 13 -17, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com